Abstract: Objective To summarize the clinical experience of 13 patients of tricuspid valve replacement and to investigate the indication and m
ethod. Methods From January 1994 to December 2005, the clinical datum of the thirteen patients suffering from tricuspid valve disease were reviewed, including rheumatic heart disease 6 cases, congenital heart disease 3 cases, infective endocarditis 3 cases and right ventricular tumor 1 case. All the cases underwent tricuspid valve replacement. Results Two reoperative rheumatic heart disease patients died early after operation and their cardiac function was New York Heart Association (NYHA) class Ⅳ before operation. The followup interval was 3 months to 12 years in 11 cases. There were 2 late death, one died of recurrence of infective endocarditis, and another died of the recurrence of the tumor. One Ebstein anomaly case’s NYHA functional recovered to class Ⅲ, eight cases’s recovered to NYHA classⅠ-Ⅱ. Conclusion The tricuspid valve disease may be a secondary lesion from many causes. Indication of tricuspid valve replacement must be strictly commanded. The late results of tricuspid valve mechanical prostheses replacement is satisfactory.
Citation： WANG Xiang,CHEN Changchun,LI Gang,TAN Min,JI Lequn,YANG Jianan,WANG Zhiwei,CHEN Weixin,JI Shangyi.. Tricuspid Valve Replacement: A Report of 13 Cases. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2007, 14(1): 16-19. doi: Copy